KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Treasury Shares: 2009-2025

Historic Treasury Shares for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to $6.3 billion.

  • Idexx Laboratories' Treasury Shares rose 24.27% to $6.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 billion, marking a year-over-year increase of 24.27%. This contributed to the annual value of $5.3 billion for FY2024, which is 19.20% up from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' Treasury Shares is $28.3 million, which was up 1.48% from $27.9 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Treasury Shares ranged from a high of $28.3 million in Q3 2025 and a low of $19,000 during Q1 2023.
  • Moreover, its 3-year median value for Treasury Shares was $1.2 million (2024), whereas its average is $12.4 million.
  • Data for Idexx Laboratories' Treasury Shares shows a peak YoY spiked of 32.30% (in 2022) over the last 5 years.
  • Idexx Laboratories' Treasury Shares (Quarterly) stood at $3.6 billion in 2021, then grew by 23.00% to $4.4 billion in 2022, then rose by 1.88% to $4.5 billion in 2023, then grew by 19.20% to $5.3 billion in 2024, then rose by 24.27% to $6.3 billion in 2025.
  • Its last three reported values are $6.3 billion in Q3 2025, $6.1 billion for Q2 2025, and $5.7 billion during Q1 2025.